• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms.

作者信息

Green Anthony, Beer Philip

出版信息

N Engl J Med. 2010 Jan 28;362(4):369-70. doi: 10.1056/NEJMc0910063.

DOI:10.1056/NEJMc0910063
PMID:20107228
Abstract
摘要

相似文献

1
Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms.骨髓增殖性肿瘤白血病转化过程中IDH1和IDH2的体细胞突变
N Engl J Med. 2010 Jan 28;362(4):369-70. doi: 10.1056/NEJMc0910063.
2
Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms.骨髓增生异常综合征及骨髓增生异常综合征/骨髓增殖性肿瘤早期和加速期IDH1和IDH2基因的突变
Leukemia. 2010 May;24(5):1094-6. doi: 10.1038/leu.2010.52. Epub 2010 Apr 8.
3
Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias.转化事件的遗传分析，这些事件将慢性骨髓增殖性肿瘤转化为白血病。
Cancer Res. 2010 Jan 15;70(2):447-52. doi: 10.1158/0008-5472.CAN-09-3783. Epub 2010 Jan 12.
4
TET2, ASXL1, IDH1, IDH2, and c-CBL genes in JAK2- and MPL-negative myeloproliferative neoplasms.TET2、ASXL1、IDH1、IDH2 和 c-CBL 基因在 JAK2 和 MPL 阴性骨髓增殖性肿瘤中的作用。
Ann Hematol. 2012 Apr;91(4):533-41. doi: 10.1007/s00277-011-1330-0. Epub 2011 Sep 9.
5
IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms.慢性期和急变期骨髓增殖性肿瘤中的 IDH1 和 IDH2 突变分析。
Leukemia. 2010 Jun;24(6):1146-51. doi: 10.1038/leu.2010.77. Epub 2010 Apr 22.
6
IDH1 and IDH2 mutations in myeloid neoplasms--novel paradigms and clinical implications.髓系肿瘤中的异柠檬酸脱氢酶1和2突变——新范例及临床意义
Haematologica. 2010 Oct;95(10):1623-7. doi: 10.3324/haematol.2010.030015.
7
IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F.原发性骨髓纤维化中的 IDH 突变可预测白血病转化和生存缩短：与 JAK2V617F 协同致白血病的临床证据。
Leukemia. 2012 Mar;26(3):475-80. doi: 10.1038/leu.2011.253. Epub 2011 Sep 13.
8
Acquired somatic mutations of isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) in preleukemic disorders.白血病前期疾病中异柠檬酸脱氢酶1和2（IDH1和IDH2）的获得性体细胞突变
Blood Cells Mol Dis. 2015 Mar;54(3):286-91. doi: 10.1016/j.bcmd.2014.11.017. Epub 2014 Nov 26.
9
Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value.在急性髓系白血病中，IDH1 和 IDH2 基因编码的获得性突变都是常见的异常：患病率和预后价值。
Blood. 2010 Sep 23;116(12):2122-6. doi: 10.1182/blood-2009-11-250878. Epub 2010 Jun 10.
10
IDH1 and IDH2 mutations are rare in pediatric myeloid malignancies.异柠檬酸脱氢酶1（IDH1）和异柠檬酸脱氢酶2（IDH2）突变在儿童髓系恶性肿瘤中较为罕见。
Leukemia. 2011 Feb;25(2):382-4. doi: 10.1038/leu.2010.307. Epub 2011 Jan 14.

引用本文的文献

1
SOHO State of the Art Updates and Next Questions | Challenging Scenarios in the Management of Myeloproliferative Neoplasms.SOHO最新技术进展与后续问题 | 骨髓增殖性肿瘤管理中的挑战性病例
Clin Lymphoma Myeloma Leuk. 2025 Jul;25(7):484-493. doi: 10.1016/j.clml.2025.02.003. Epub 2025 Feb 16.
2
The Leukemic Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs).白血病突变损害原代人造血干细胞和祖细胞（HSPCs）的髓系和红系细胞分化。
Cancers (Basel). 2024 Jul 27;16(15):2675. doi: 10.3390/cancers16152675.
3
neomorphic mutation confers sensitivity to vitamin B12 in .
neomorphic 突变使. 对维生素 B12 敏感。
Life Sci Alliance. 2024 Jul 15;7(10). doi: 10.26508/lsa.202402924. Print 2024 Oct.
4
DNA methylation in human diseases.人类疾病中的DNA甲基化
Heliyon. 2024 Jun 4;10(11):e32366. doi: 10.1016/j.heliyon.2024.e32366. eCollection 2024 Jun 15.
5
Management of isocitrate dehydrogenase 1/2 mutated acute myeloid leukemia.异柠檬酸脱氢酶 1/2 突变型急性髓系白血病的治疗。
Leukemia. 2024 May;38(5):927-935. doi: 10.1038/s41375-024-02246-2. Epub 2024 Apr 10.
6
Epigenetics in myeloproliferative neoplasms.骨髓增殖性肿瘤中的表观遗传学
Front Oncol. 2023 Jul 13;13:1206965. doi: 10.3389/fonc.2023.1206965. eCollection 2023.
7
Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision Oncology.血栓性骨髓增殖性肿瘤的分子遗传学：对精准肿瘤学的启示
Diagnostics (Basel). 2023 Jan 3;13(1):163. doi: 10.3390/diagnostics13010163.
8
Genetic basis and molecular profiling in myeloproliferative neoplasms.骨髓增殖性肿瘤的遗传基础和分子谱分析。
Blood. 2023 Apr 20;141(16):1909-1921. doi: 10.1182/blood.2022017578.
9
Characterization of pyruvate metabolism and citric acid cycle patterns predicts response to immunotherapeutic and ferroptosis in gastric cancer.丙酮酸代谢和柠檬酸循环模式的特征可预测胃癌对免疫治疗和铁死亡的反应。
Cancer Cell Int. 2022 Oct 13;22(1):317. doi: 10.1186/s12935-022-02739-z.
10
Diagnostic and Therapeutic Perspectives Associated to Cobalamin-Dependent Metabolism and Transcobalamins' Synthesis in Solid Cancers.与固体肿瘤中钴胺素依赖代谢和转钴胺素合成相关的诊断和治疗观点。
Nutrients. 2022 May 14;14(10):2058. doi: 10.3390/nu14102058.